Inari Medical Inc (NARI) concluded trading on Thursday at a closing price of $79.40, with 3.87 million shares of worth about $307.4 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 35.45% during that period and on January 16, 2025 the price remained unchanged. Currently the company’s common shares owned by public are about 58.44M shares, out of which, 50.51M shares are available for trading.
Stock saw a price change of 0.13% in past 5 days and over the past one month there was a price change of 42.83%. Year-to-date (YTD), NARI shares are showing a performance of 55.53% which increased to 34.76% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $36.73 but also hit the highest price of $79.69 during that period. The average intraday trading volume for Inari Medical Inc shares is 2.03 million. The stock is currently trading 26.03% above its 20-day simple moving average (SMA20), while that difference is up 40.86% for SMA50 and it goes to 63.95% higher than SMA200.
Inari Medical Inc (NASDAQ: NARI) currently have 58.44M outstanding shares and institutions hold larger chunk of about 89.38% of that.
The stock has a current market capitalization of $4.65B and its 3Y-monthly beta is at 0.96. It has posted earnings per share of -$1.35 in the same period. It has Quick Ratio of 1.40 while making debt-to-equity ratio of 0.08. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for NARI, volatility over the week remained 0.24% while standing at 4.56% over the month.
Stock’s fiscal year EPS is expected to drop by -2283.33% while it is estimated to increase by 122.26% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Oppenheimer on December 17, 2024 offering an Outperform rating for the stock and assigned a target price of $75 to it. Coverage by Stifel stated Inari Medical Inc (NARI) stock as a Hold in their note to investors on September 18, 2024, suggesting a price target of $50 for the stock. On September 03, 2024, Leerink Partners Initiated their recommendations, while on August 09, 2024, Deutsche Bank Initiated their ratings for the stock with a price target of $68. Stock get an Outperform rating from William Blair on July 25, 2024.
